Old Dominion University
UEI CTLVX9M7AMR4 · VA · subsidiary of Eastern Virginia Medical School · SAM.gov record ↗
$371K
FY2025 obligations
10
Contract awards
Jun 24, 2013
First action
May 14, 2026
Latest action
Obligations by agency
- Department Of Health And Human Services$349K
- Department Of Defense$22K
Obligations by NAICS
Monthly obligations
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
May 25
Jul 25
Jan 26
Apr 26
May 26
Contracts ending within 18 months (recompete watch)
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N94020F00001 ↗ | TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES. 75N94020D00020/75N94020F00001 8/1/2020 - 7/31 | National Institutes Of Health | 541714 | $2K | Jul 31, 2020 | Jul 30, 2026 |
| 75N94025F00001 ↗ | NICHD: SERVICE: CCTN LB PHASE 2B CLINICAL TRIAL: NON-SEVERABLE | National Institutes Of Health | 541714 | $509K | Jul 31, 2025 | Dec 30, 2027 |
Largest awards
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N94025F00001 ↗ | NICHD: SERVICE: CCTN LB PHASE 2B CLINICAL TRIAL: NON-SEVERABLE | National Institutes Of Health | 541714 | $509K | Jul 31, 2025 | Dec 30, 2027 |
| N0622A24F00LQ ↗ | TUITION AND FEES | Department Of The Navy | 611310 | $26K | May 20, 2024 | May 29, 2025 |
| 75N94020F00001 ↗ | TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES. 75N94020D00020/75N94020F00001 8/1/2020 - 7/31 | National Institutes Of Health | 541714 | $2K | Jul 31, 2020 | Jul 30, 2026 |
| HHSN275201300019I ↗ | CCTN - FEMALE SITES | National Institutes Of Health | 541712 | $0 | Jun 24, 2013 | — |
| 75N94018F00005 ↗ | CONTRACEPTIVE CLINICAL TRIALS NETWORK - FEMALE SITES POP: 9/28/18 - 07/14/25 TO EVALUATE IN OBESE AND NON-OBESE WOMEN THE PHARMACOKINETICS (PK) AND THE PHARMACODYNAMIC (PD) EFFECTS, CYCLE CONTROL, AND SAFETY OF LEVONORGESTREL BUTANOATE (LB) FORMULA | National Institutes Of Health | 541712 | $0 | Sep 24, 2018 | Jul 13, 2026 |
| HHSN27500002 ↗ | OLD DOMINION UNIVERSITY RESEARCH FOUNDATION: A MULTI-CENTER, RANDOMIZED STUDY TO EVALUATE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE, CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL LOW DOSE ULIPRISTAL ACETATE HHSN275201300019I/HHSN275200002 | National Institutes Of Health | 541712 | $-506 | Jul 15, 2013 | Jan 30, 2022 |
| HHSN27500004 ↗ | NICHD: R&D: CLINICAL EVALUATION OF LONG-ACTING REVERSIBLE CONTRACEPTIVES (LARC) | National Institutes Of Health | 541712 | $-3K | Sep 21, 2015 | Sep 29, 2022 |
| N0622A23F00EW ↗ | TUITION AND FEES | Department Of The Navy | 611310 | $-4K | Jul 31, 2023 | Jun 27, 2024 |
| 75D30123P18126 ↗ | AORRP SERVICES | Centers For Disease Control And Prevention | 611310 | $-62K | Sep 17, 2023 | Sep 28, 2024 |
| 75N94023F00001 ↗ | 75N94020D00020 - 75N94023F00001-OVAPRENE PHASE I: PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL | National Institutes Of Health | 541714 | $-96K | Sep 27, 2023 | Mar 26, 2025 |